BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
Add Report.az to preferred Google sources
Stay up to date with the top news!
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Latest News
14:21
Wadephul: Constitutional change in Armenia necessary to finalize peace deal with Azerbaijan
Region
14:13
Hong Kong–Papua New Guinea flight makes emergency landing in southern Philippines
Other countries
13:56
Wadephul: Azerbaijan is a reliable and important energy supplier to Germany and Europe
Energy
13:53
Photo
Farid Gayibov discusses regional sports development with representatives of federations
Individual sports
13:31
Photo
President Ilham Aliyev holds expanded meeting with President of Vietnam - Updated
Foreign policy
13:20
German companies to visit Azerbaijan to explore sustainable tourism opportunities
Tourism
13:14
31 injured in Türkiye minibus accident while transporting deceased person's body
Region
12:54
Temperatures to reach 18°C on Sunday
Ecology
12:35
Four killed, 35 injured in fire at power plant in Iraq
Other countries